Annual report [Section 13 and 15(d), not S-K Item 405]

Stockholders??? Equity (Deficit) (Tables)

v3.25.3
Stockholders’ Equity (Deficit) (Tables)
12 Months Ended
Sep. 30, 2025
Equity [Abstract]  
Schedule of Fair Value of Assumptions

 

Stock price per share   $ 1.21  
Term (years)     5.00  
Expected volatility     99.84 %
Dividend yield     %
Risk-free interest rate     3.84 %
Schedule of Warrants Outstanding

As of September 30, 2025, the following equity-classified warrants and related terms were outstanding:

 

    Warrants Outstanding     Exercise Price     Expiration Date
Common stock warrants August 2021     14,031     $ 2,094.40     August 24, 2026
Underwriter warrants August 2021     284     $ 2,618     August 19, 2026
Chanticleer warrants     6     $ 144,144.00 - $224,224.00     April 30, 2027 - December 17, 2028
Series C warrants     2,297     $ 7,860.16     October 16, 2025
Series 3 warrants     1,566     $ 717.024     August 15, 2027
Common stock warrants February 2023     31,563     $ 190.08     February 10, 2028
Underwriter warrants February 2023     1,933     $ 237.60     February 8, 2028
Common stock private placement warrants June 2023     28,409     $ 12.4000     June 21, 2029
Placement agent warrants June 2023     852     $ 118.7824     December 30, 2026
Common stock warrants October 2023     354,994     $ 9.6000     October 27, 2028
Underwriter warrants October 2023     10,664     $ 16.0000     October 24, 2028
Placement agent warrants June 2024     14,142     $ 14.8800     June 19, 2029
Common stock warrants June 2024     623,125     $ 12.4000     June 21, 2029
Common stock warrants November 2024     611,110     $ 4.5000     November 7, 2029
Common stock PIPE warrants December 2024     350,000     $ 2.1000     December 9, 2029
Common stock warrants July 2025     865,052     $ 1.1560     June 30, 2030
Common stock PIPE warrants July 2025     8,800,000     $ 1.2500     July 14, 2030
Common stock warrants July 2025     3,200,000     $ 1.2500     July 14, 2030
Total     14,910,028